REFRACTORY ACUTE LYMPHOID LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR t-cell combo shows promise for tough leukemia
Disease control Recruiting nowThis study tests two different CAR T-cell treatments for children and young adults with B-cell acute lymphoblastic leukemia that has come back or not responded to standard therapy. One group gets a combination of two types of CAR T-cells (CD19 and CD22), while the other gets one …
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 17, 2026 05:18 UTC
-
New combo therapy aims to keep cancer-fighting cells from burning out
Disease control Recruiting nowThis study looks at whether adding cytokine-induced killer (CIK) cells can prevent CAR-T cells from wearing out too early in people with relapsed or refractory B-cell acute lymphoblastic leukemia. About 213 children and young adults will be randomly assigned to receive either sta…
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 05, 2026 11:54 UTC